Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a on the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study - Bastianello, S; Giugni, E; Amato, M P (BMC Neurol, 2011)
et al.